GLP-1s are breaking life insurance

Post by eru » Tue, Jul 15, 2025, 7:44 AM UTC

Jalad wrote: post #487

eru wrote: post #401

Earlier quoted context omitted.

> [...] along with the lack of health education in schools. I don't think that's too much of a factor? I mean, check how much (or rather how little) people learn of the stuff that _is_ covered in school. Tweaking the curriculum would just mean that instead of not paying attention in algebra, students would not pay attention in 'health education class'.

In my school there was a strong emphasis on what a healthy diet is baked into the curriculum. Along with my family's relatively healthy cooking, that set me up for cooking and eating well on my own through college and life after that. I would edge away from takes related to "it just wouldn't work" I mean the education system is its own mess for other reasons, but it's not a complete failure

Post by eru » Tue, Jul 15, 2025, 7:46 AM UTC

int_19h wrote: post #526

pmyteh wrote: post #431

Earlier quoted context omitted.

Depending on how transformative the effects are (and the price drop possible upon genericisation) then there could be a compulsory licensing trade to do here. The drug companies are presumably pricing optimally for profit (but not for maximum public benefit, for which the optimum price is ~0). You could calculate the net present value of the drug companies' total profits attributable to the patent, add on 10% as a bo…

That is exactly what I have in mind. "Eminent domain" doesn't mean just taking things with no recompense, but I don't think the company should be entitled to profit maximization at the expense of literally billions of people worldwide.

Post by jart » Tue, Jul 15, 2025, 8:47 AM UTC

int_19h wrote: post #565

jart wrote: post #539

Earlier quoted context omitted.

The people can wait seven years for the patent to expire.

Patents are a form of artificial monopoly that only exists because the people (acting through their government as a representative of their will) decided to have them, and did so because they presumably are a net social benefit. Consequently, governments are not obligated to treat them as sacrosanct, and most certainly not in a case where they are not beneficial to public interests.

Post by sroussey » Tue, Jul 15, 2025, 9:17 AM UTC

randallsquared wrote: post #313

abruzzi wrote: post #302

Earlier quoted context omitted.

Mounjaro uses a single use fully autometed injector--clean your skin, remove the cap, press the injector against your skin, then press a button. A springloaded needle penetrates you skin and a spring loaded plunger injects the medicine. You have no way to pull backthe plunger to see if you are in a vein/artery. I've never used Ozempic, but my understanding was it used a device similar to insulin pens--dial you dosage…

This is right. It's all or nothing, and there's no "pull back" functionality.

Post by nopcode » Tue, Jul 15, 2025, 11:20 AM UTC

jtrn wrote: post #204

Clinical psychologist here in Norway, and just my subjective experience: People stop GLP1 agonists for the following reasons, in descending order: - They want to enjoy eating again. - Medications are a hassle. - Worry about long-term effects, even if there is no alarming evidence for now. - Price (we are a spoiled/rich country). - Other (like hating needles, feeling bad for taking medications that others need more, b…